N03AX18 LAKOSAMID - Lacosamide Glenmark
TED · 517489-2026Award noticeawardedNo deadline given
Value
Estimated€688,859 · 16,666,259.24 CZK
Awarded€687,326 · 16,629,163.44 CZK
WinnerPROMEDICA PRAHA GROUP, a.s.
Who already wins at this buyer
Firms with recorded awards from Fakultní nemocnice u sv. Anny v Brně in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 9 | €3,505,920 | 2026-07-24 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 7 | €1,314,810 | 2026-07-22 |
| PROMEDICA PRAHA GROUP, a.s. | 5 | €484,148 | 2026-07-14 |
| ViaPharma s.r.o. | 4 | €2,481,288 | 2026-07-16 |
| Bristol-Myers Squibb spol. s r.o. | 3 | €4,024,644 | 2026-07-14 |
Full buyer profile: what Fakultní nemocnice u sv. Anny v Brně buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Předmětem veřejné zakázky jsou průběžné dodávky léčiv s obsahem účinné látky N03AX18 LAKOSAMID - Lacosamide Glenmark po dobu 4 let.